[1]

[2]

[3]

HUANG Ting, XU Yan, SHI Qingxing, PENG Ying. Roles of miR-944 and MARCH7 mRNA in prognosis assessment of non-small cell lung cancer patients [J]. Laboratory Medicine, 2025, 40(12): 1159-1164.

[4]

[5]

[6]

[7]

[8]

CHANG Nan, WEI Yali, LU Qifeng, LI Tian, HOU Tingting, LI Yuan, ZHU Mengyu, SHEN Yajuan. A machine learning early warning model for acute promyelocytic leukemia based on blood cell analyzer parameters [J]. Laboratory Medicine, 2025, 40(12): 1190-1196.

[9]

. [J]. Laboratory Medicine, 2025, 40(12): 1197-1202.

[10]

. [J]. Laboratory Medicine, 2025, 40(12): 1216-1221.

[11]

. [J]. Laboratory Medicine, 2025, 40(12): 1222-1226.

[12]

[13]

[14]

[15]

LIU Chunyan, NIU Shumin, DENG Zhaohui, LIANG Mengjie, ZHANG Xin. Establishing the reference ranges for AFP，CEA，CA72-4 and CA19-9 in Urumqi region by indirect method [J]. Laboratory Medicine, 2025, 40(11): 1053-1058.

组别	TP(IU/mL)	AST(g/L)	CK(IU/mL)	CK-MB(IU/mL)	HBDH(IU/mL)	LDH(IU/mL)
溶血前	37.1±23.1	72.6±3.8	127.7±68.5	6.5±1.3	144.1±62.2	172.3±54.5
溶血后	60.9±19.5^*	79.2±4.6^*	168.9±78.6^*	84.6±16.4^*	356.6±140.2^*	401.9±82.4^*
Hb校正值	36.8±23.5	74.6±3.5	129.6±65.8	5.3±1.4	143.6±63.8	183.9±52.4
组别	K⁺(mmol/L)	Na⁺(mmol/L)	Alb(g/L)	TG(mmol/L)		HDL(mmol/L)
溶血前	3.9±1.2	142.2±5.5	41.6±1.9	1.5±0.5		1.4±0.4
溶血后	6.3±2.2^*	123.1±6.2^*	41.6±1.8	1.5±0.7		1.4±0.6
Hb校正值	3.7±1.6	144.6±5.7	41.5±1.2	1.6±0.1		1.4±0.3

组别	TP(IU/mL)	AST(g/L)	CK(IU/mL)	CK-MB(IU/mL)	HBDH(IU/mL)	LDH(IU/mL)
溶血前	37.1±23.1	72.6±3.8	127.7±68.5	6.5±1.3	144.1±62.2	172.3±54.5
溶血后	60.9±19.5^*	79.2±4.6^*	168.9±78.6^*	84.6±16.4^*	356.6±140.2^*	401.9±82.4^*
Hb校正值	36.8±23.5	74.6±3.5	129.6±65.8	5.3±1.4	143.6±63.8	183.9±52.4
组别	K⁺(mmol/L)	Na⁺(mmol/L)	Alb(g/L)	TG(mmol/L)		HDL(mmol/L)
溶血前	3.9±1.2	142.2±5.5	41.6±1.9	1.5±0.5		1.4±0.4
溶血后	6.3±2.2^*	123.1±6.2^*	41.6±1.8	1.5±0.7		1.4±0.6
Hb校正值	3.7±1.6	144.6±5.7	41.5±1.2	1.6±0.1		1.4±0.3

ΔHb	ΔTP	ΔAST	ΔCK	ΔCK-MB	ΔHBDH	ΔLDH	ΔK⁺	ΔNa⁺
0.8	2.2	10	6	21	44	15	0.14	-0.42
1.2	2.6	12	10	31	52	54	0.43	-5.4
2.1	4.2	17	23	53	110	127	1.12	-8.9
3.6	5.2	23	36	73	165	175	2.01	-15.4
5.7	7.7	28	46	96	268	264	2.83	-23.4
6.2	8.8	30	53	104	307	328	3.49	-29.4
7.2	10.5	35	62	117	371	406	4.02	-34.7

ΔHb	ΔTP	ΔAST	ΔCK	ΔCK-MB	ΔHBDH	ΔLDH	ΔK⁺	ΔNa⁺
0.8	2.2	10	6	21	44	15	0.14	-0.42
1.2	2.6	12	10	31	52	54	0.43	-5.4
2.1	4.2	17	23	53	110	127	1.12	-8.9
3.6	5.2	23	36	73	165	175	2.01	-15.4
5.7	7.7	28	46	96	268	264	2.83	-23.4
6.2	8.8	30	53	104	307	328	3.49	-29.4
7.2	10.5	35	62	117	371	406	4.02	-34.7

RichHTML

PDF (PC)

[1]	陈海斌,梁业宾,黄慧嫦,等.标本溶血对电化学发光免疫法结果的影响[J].检验医学,2012,27(8):651-653.
[2]	陈益川, 张德亭, 李莉莉,等.3 种采血管制备的标本对 6 种生化指标检测结果的影响[J].检验医学,2014,29(4):402-404.
[3]	潘知焕. 围产期影响早产儿贫血程度的因素分析[J].健康研究,2014,34(6):644-645.
[4]	曾琼. 56例标本溶血对常规生化检验结果影响分析[J].中国实用医药,2014,9(10):65-66.
[5]	王根芬. 孕妇血清抗-A(B) 抗体检测与新生儿溶血的临床意义[J].检验医学,2013,28(10):928-929.
[6]	孙海芳,喻芳明,方巧兰. 新生儿ABO 溶血病患儿母亲孕期 IgG 抗 A/B 效价的动态监测[J].检验医学,2011,26(12): 850-853.
[7]	谭琳琳,黄田海,何华平,等.1 337名离退休老干部体检生化结果分析[J].检验医学,2012,27(12):1087-1089.